Yu-Jay Corp.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) in Combo Tablet for Patients Receiving Atripla With Viral Suppression in Taiwan (NCT03595709) | Yu-Jay Corp. | 2018-12-06 |
Track Yu-Jay Corp. automatically
Every clearance here is in the API, with alerts when new ones post.